Who
Marianne Zhen
Chief Accounting Officer
Company insider
Files Form 4 as: Chief Accounting Officer, Innoviva.
In numbers
- Trades disclosed
- 65
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $368K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Aug 2018
- Last trade
- 20 Aug 2026
- Last filed
- 24 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Aug 2026filed 24 Aug 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $24K1,127 at $21.00 | filing |
| 20 Aug 2026filed 24 Aug 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $24K1,127 at $21.00 | filing |
| 20 May 2026filed 22 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $25K1,127 at $22.24 | filing |
| 20 May 2026filed 22 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $25K1,127 at $22.24 | filing |
| 4 May 2026filed 6 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —12,766 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —31,500 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —31,500 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —12,766 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $58K2,460 at $23.39 | filing |
| 20 Feb 2026filed 24 Feb 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $58K2,460 at $23.39 | filing |
| 20 Nov 2025filed 24 Nov 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $21K992 at $21.16 | filing |
| 20 Aug 2025filed 22 Aug 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $20K991 at $19.95 | filing |
| 20 May 2025filed 22 May 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $19K992 at $18.78 | filing |
| 24 Feb 2025filed 26 Mar 2025 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,300 at $0.00 | filing |
| 24 Feb 2025filed 26 Mar 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | $162K8,938 at $18.08 | filing |
| 20 Feb 2025filed 24 Feb 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $46K2,565 at $18.07 | filing |
| 20 Nov 2024filed 22 Nov 2024 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $19K976 at $19.15 | filing |
| 15 Nov 2024filed 22 Nov 2024 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —300 at $0.00 | filing |
| 20 Aug 2024filed 22 Aug 2024 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $18K975 at $18.49 | filing |
| 20 May 2024filed 21 May 2024 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code F | $16K976 at $16.13 | filing |
News
No headline names them, or the companies they trade most, lately.